Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.7 (
DNA polymerase
)
17,007
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
3'-Amino-3'-deoxythymidine decreased the incorporation of [2-14C]thymidine into DNA of L1210 cells in vitro, and produced an accumulation of [2-14C]thymidine di- and triphosphate. The extent of these effects varied with the amount of recovery time after removal of
3'-amino-3'-deoxythymidine
prior to addition of labeled thymidine. The distribution of radioactivity in the acid-soluble fraction derived from [3H]
3'-amino-3'-deoxythymidine
was as follows: 50% as
3'-amino-3'-deoxythymidine
, 20% as the monophosphate, 10% as the diphosphate, and 20% as the triphosphate derivatives. No incorporation of [3H]
3'-amino-3'-deoxythymidine
into L1210 DNA could be detected. 3'-Amino-3'-deoxythymidine-5'-triphosphate is a competitive inhibitor against dTTP with a Ki of 3.3 microM, whereas the Km for dTTP was 8 microM using activated calf thymus DNA as the template and DNA polymerase-alpha. These data indicate that a major site of inhibition by
3'-amino-3'-deoxythymidine
is inhibition of the
DNA polymerase
reaction.
...
PMID:Molecular basis of the antineoplastic activity of 3'-amino-3'-deoxythymidine. 672 65